Literature DB >> 32030244

Benefits may not outweigh risks of low molecular weight heparin (LMWH) in early postoperative thromboprophylaxis following minimally invasive cardiac surgery: a propensity score-matched analysis.

Wei Li1,2, Pei Wang1, Shiguan Le1,3, Wang Xi1, Jing Wang1, Liang Yin1, Qing Wang1, Yufeng Zhang1, Zhinong Wang1.   

Abstract

BACKGROUND: Whether the benefits of early prophylactic anticoagulation by low molecular weight heparin (LMWH) would outweigh its possible harms in patients after minimally invasive cardiac surgery (MICS) remains contentious. The aims of this study were to define the incidence of venous thromboembolism (VTE) and to assess whether early prophylactic anticoagulation by LMWH postoperatively was indeed effective in reducing VTE without increasing risk of complications after MICS.
METHODS: This investigation was a single-center, retrospective, propensity score-matched analysis study. A total of 473 patients underwent MICS, of whom 257 received prophylactic anticoagulation with LMWH (LMWH group) in the early postoperative period and 216 were not treated with LMWH (Control group). The main outcome measurements included the incidence of embolism events and major bleeding events, the volume of erythrocyte transfusion, the volume of drainage and the duration of drainage after MICS. In addition, the incidence of poor wound healing, the mechanical ventilation time, ICU stay time and postoperative hospitalization time were also documented.
RESULTS: There were fewer embolic events (P=1.000) and a higher rate of major bleeding events (P=0.008) in the LMWH group than the Control group, and their magnitude and significance were maintained in the propensity matched analysis. In the matched cohorts, there was no significant difference in the total volume of red blood cell transfusion (P=0.552), assisted mechanical ventilation time (P=0.542), and the ICU stay time (P=0.166) between the two groups; while the volume of drainage (P<0.001) and the duration of drainage (P<0.001) in the LMWH group were significantly more than the Control group, and the incidence of poor wound healing (P=0.009) and the postoperative hospitalization time (P<0.001) were significantly increased in the LMWH group.
CONCLUSIONS: Early prophylactic anticoagulation with LMWH could not reduce the incidence of embolism events after MICS. Instead, it might increase postoperative major bleeding events and prolong drainage tube indwelling time and the length of hospital stay. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Minimally invasive surgery; blood transfusion; cardiac surgical procedures; drainage; heparin; low-molecular-weight; venous thrombosis

Year:  2019        PMID: 32030244      PMCID: PMC6988030          DOI: 10.21037/jtd.2019.11.56

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  34 in total

Review 1.  Minimally-invasive valve surgery.

Authors:  Jan D Schmitto; Suyog A Mokashi; Lawrence H Cohn
Journal:  J Am Coll Cardiol       Date:  2010-08-03       Impact factor: 24.094

Review 2.  Guideline on antiplatelet and anticoagulation management in cardiac surgery.

Authors:  Joel Dunning; Michel Versteegh; Alessandro Fabbri; Alain Pavie; Philippe Kolh; Ulf Lockowandt; Samer A M Nashef
Journal:  Eur J Cardiothorac Surg       Date:  2008-03-28       Impact factor: 4.191

3.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

Review 4.  Mechanistic view of risk factors for venous thromboembolism.

Authors:  Pieter H Reitsma; Henri H Versteeg; Saskia Middeldorp
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03       Impact factor: 8.311

5.  2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodríguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; José Luis Zamorano
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2018-02

6.  Incidence of Postoperative Deep Venous Thrombosis Is Higher among Cardiac and Vascular Surgery Patients as Compared with General Surgery Patients.

Authors:  Faisal Aziz; Mayank Patel; Gail Ortenzi; Amy B Reed
Journal:  Ann Vasc Surg       Date:  2015-02-28       Impact factor: 1.466

Review 7.  Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery.

Authors:  Marcello Di Nisio; Frank Peinemann; Ettore Porreca; Anne W S Rutjes
Journal:  Cochrane Database Syst Rev       Date:  2015-06-19

8.  Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.

Authors:  Philippe Meurin; Jean Yves Tabet; Hélène Weber; Nathalie Renaud; Ahmed Ben Driss
Journal:  Circulation       Date:  2006-01-31       Impact factor: 29.690

9.  Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery.

Authors:  Alessandro Parolari; Luciana Mussoni; Marta Frigerio; Moreno Naliato; Francesco Alamanni; Andrea Galanti; Giuseppe Fiore; Fabrizio Veglia; Elena Tremoli; Paolo Biglioli; Marina Camera
Journal:  J Thorac Cardiovasc Surg       Date:  2005-08       Impact factor: 5.209

Review 10.  Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.

Authors:  Andrea L Jorgensen; Richard J FitzGerald; James Oyee; Munir Pirmohamed; Paula R Williamson
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more
  1 in total

1.  Venous thromboembolism prophylaxis after minimally-invasive cardiac surgery: harm or benefit?

Authors:  Angelo Carretta; Elisabetta Lapenna
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.